Multiplex Assays Market Scenario
Multiplex Assays are used to detect multiple analytes in a single run of the assay. These are widely used in genomics to quantify mRNAs, DNAs, and proteins to assess the effect of DNA mutation on various biomolecules in the given sample. With multiplex assays, scientists can gain more information about a single protein or series of proteins within a single well or reaction of an experiment.
This not only helps the scientists to conserve time and cost but also save on their sample quantity. Researchers are using multiplex assays to detect cellular regulatory events occurring in chronic diseases such as cancer. The multiplex assay market is dominated by North America due to increase in R&D activities and rising R&D expenditure in this region. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), the U.S. carries out nearly half of the world’s pharmaceutical Research and Development (R&D) and possesses the intellectual property rights on most of the newly developed medicines, thus driving the market growth in this region.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/6135 .
Multiplex Assays Market Top 10 Players:
Thermo Fisher Scientific,
Becton Dickinson and Company,
Meso Scale Diagnostics,
Olink, Seegene and others.
Multiplex Assays Market Segmentation
The Global Multiplex Assays Market is segmented on the basis of product and service, type, technology, application, and end-user. The multiplex assays market, by product and service, is sub-segmented into consumables, instruments, software and services, and others. On the basis of type, the market is categorized into protein multiplex assays, nucleic acid multiplex assays, cell-based multiplex assays, and others. Protein multiplex assays are further sub-segmented into planar protein assays, bead-based protein assays, and others.
Nucleic acid multiplex assays are further sub-segmented into planar nucleic acid assays, bead-based nucleic acid assays, and others. The technology segment includes flow cytometry, fluorescence detection, luminescence, real-time multiplex PCR, and others. On the basis of application, the market is categorized into research and development and clinical diagnostics. The research and development segment includes drug discovery and development and biomarker discovery and validation. The clinical diagnostics segment includes infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, metabolism and endocrinology disorders, and others. On the basis of end-user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories, and others.
Multiplex Assays Market Regional Analysis
The Multiplex Assays Market is dominated by North America owing to strong R&D activities in this region. According to the International Trade Administration (ITA), the United States is the leading country in Biopharmaceutical Research and Development (R&D) activities and conducts around half the world’s Research and Development (R&D) in pharmaceuticals. Increased adoption of technologically advanced devices and the high amount of healthcare expenditure drive the market in this region.
It is estimated that Europe stood second in the global multiplex assays market. Increasing healthcare expenditure and health care activities and increase in the use of diagnostics and unmet needs for health care are driving the growth of this market in Europe. The use of multiplex assays for diagnostics influences the market growth in this region. According to the European Heart Network (2017), 45% of deaths in Europe are due to cardiovascular diseases. Thus, increasing prevalence of cardiovascular diseases in Europe drives the market growth. Furthermore, growing biotechnology sector in Europe is expected to boost the market in this region.
Asia Pacific was projected to be the fastest growing region for the global multiplex assays market. Key factors such as rising number of patient population, increase in the prevalence of chronic diseases, and growing research and development activities in pharmaceuticals for the treatment of diseases, such as cancer and other infectious diseases influence the market in this region.
The Middle East and Africa holds the least share in the global multiplex assays market due to the presence of stringent government policies and poor economies. However, increasing investment by private market players in this region can boost the market growth.
MAJOR TABLE OF CONTENTS FOR Multiplex ASSAYS MARKET RESEARCH REPORT – FORECAST TO 2023:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Ask to Experts @ https://www.marketresearchfuture.com/enquiry/6135 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar